Cellular Intelligence Expands Scientific Advisory Board with Notable Experts in AI and Cell Biology
On September 21, 2026, Cellular Intelligence, a pioneering AI firm focused on cell signaling, made a significant announcement with the addition of four renowned experts to its Scientific Advisory Board. This team comprises Yann LeCun, a 2018 Turing Award laureate; Robert 'Bob' Langer, a co-founder of Moderna; Jens Nielsen, CEO of the BioInnovation Institute; and Fabian Theis, director at Helmholtz Munich. Each member brings a wealth of expertise, innovation, and a proven track record in their respective fields.
Yann LeCun, known for his groundbreaking work in deep learning, serves as a Silver Professor at New York University. His insights into AI systems harness the power of data to create predictive models that are crucial for understanding complex biological processes.
"The models that interest me learn how the world works from data and predict what happens when we act on it," said LeCun, emphasizing the rich potential of cellular data. He views Cellular Intelligence as an exciting venture that merges new methodologies for cellular data acquisition with advanced models of cellular dynamics.
Robert Langer, considered one of the most cited engineers globally, has left a remarkable mark on the fields of drug delivery and tissue engineering. He expressed enthusiasm for the potential of connecting fundamental cellular behavior with practical medical applications.
"If we can better predict how cells respond to an intervention, we can ask more precise questions, design better experiments, and open new possibilities for patients," Langer shared, reflecting his commitment to advancing medicine through science.
Jens Nielsen, who is also a professor of systems biology, emphasizes the importance of understanding cellular systems in their entirety. His approach combines rigorous quantitative models and carefully designed experiments aimed at developing new therapeutic possibilities.
"I am eager to contribute to Cellular Intelligence's mission of achieving a more predictable cell engineering approach," noted Nielsen, showcasing the importance of collaboration in scientific advancements.
Lastly, Fabian Theis, recognized for his contributions to predictive modeling in biology, highlighted the potential of integrating rich experimental data with predictive models.
"This combination creates an opportunity to test how well models generalize across biological contexts," Theis stated, pointing to the ongoing need for systematic learning in scientific research.
The formation of this advisory board aligns with Cellular Intelligence's broader goals of addressing critical challenges in AI and medicine, particularly in understanding the underlying logic governing cell changes. The company aims to translate its foundational research into therapeutic applications that could significantly impact patient care.
Micha Breakstone, CEO and co-founder of Cellular Intelligence, believes that this unique collaboration will allow the company to bridge the gap between artificial intelligence and biological experimentation - a crucial step in the advancement of medicine.
With these expert appointments, Cellular Intelligence is setting the stage for exciting developments in cell biology and therapeutic innovation, potentially transforming how we understand and manipulate cellular behaviors. This enhances the company's commitment to holistic approaches in regenerative medicine and beyond. As the landscape of biology continues to evolve along with AI technologies, the implications for patient treatment and health regimens could be monumental, heralding a new era of scientific progress.
Cellular Intelligence operates at the intersection of AI and biomedical innovation, focusing on creating a universal foundation model that facilitates understanding, prediction, and control of cellular behavior. Located in Boston, the company integrates experimental biology and machine learning to pioneer new therapeutic pathways, setting a high standard for regenerative medicine and scientific exploration. To learn more about their initiatives and updates, visit Cellular Intelligence's website.
Yann LeCun, known for his groundbreaking work in deep learning, serves as a Silver Professor at New York University. His insights into AI systems harness the power of data to create predictive models that are crucial for understanding complex biological processes.
"The models that interest me learn how the world works from data and predict what happens when we act on it," said LeCun, emphasizing the rich potential of cellular data. He views Cellular Intelligence as an exciting venture that merges new methodologies for cellular data acquisition with advanced models of cellular dynamics.
Robert Langer, considered one of the most cited engineers globally, has left a remarkable mark on the fields of drug delivery and tissue engineering. He expressed enthusiasm for the potential of connecting fundamental cellular behavior with practical medical applications.
"If we can better predict how cells respond to an intervention, we can ask more precise questions, design better experiments, and open new possibilities for patients," Langer shared, reflecting his commitment to advancing medicine through science.
Jens Nielsen, who is also a professor of systems biology, emphasizes the importance of understanding cellular systems in their entirety. His approach combines rigorous quantitative models and carefully designed experiments aimed at developing new therapeutic possibilities.
"I am eager to contribute to Cellular Intelligence's mission of achieving a more predictable cell engineering approach," noted Nielsen, showcasing the importance of collaboration in scientific advancements.
Lastly, Fabian Theis, recognized for his contributions to predictive modeling in biology, highlighted the potential of integrating rich experimental data with predictive models.
"This combination creates an opportunity to test how well models generalize across biological contexts," Theis stated, pointing to the ongoing need for systematic learning in scientific research.
The formation of this advisory board aligns with Cellular Intelligence's broader goals of addressing critical challenges in AI and medicine, particularly in understanding the underlying logic governing cell changes. The company aims to translate its foundational research into therapeutic applications that could significantly impact patient care.
Micha Breakstone, CEO and co-founder of Cellular Intelligence, believes that this unique collaboration will allow the company to bridge the gap between artificial intelligence and biological experimentation - a crucial step in the advancement of medicine.
With these expert appointments, Cellular Intelligence is setting the stage for exciting developments in cell biology and therapeutic innovation, potentially transforming how we understand and manipulate cellular behaviors. This enhances the company's commitment to holistic approaches in regenerative medicine and beyond. As the landscape of biology continues to evolve along with AI technologies, the implications for patient treatment and health regimens could be monumental, heralding a new era of scientific progress.
About Cellular Intelligence
Cellular Intelligence operates at the intersection of AI and biomedical innovation, focusing on creating a universal foundation model that facilitates understanding, prediction, and control of cellular behavior. Located in Boston, the company integrates experimental biology and machine learning to pioneer new therapeutic pathways, setting a high standard for regenerative medicine and scientific exploration. To learn more about their initiatives and updates, visit Cellular Intelligence's website.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.